Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology/Complications

Determinants of Exercise Capacity in Patients With Type 2 Diabetes

  1. Zhi You Fang, MBBS, PHD,
  2. James Sharman, PHD,
  3. Johannes B. Prins, MBBS, PHD and
  4. Thomas H. Marwick, MBBS, PHD
  1. Department of Medicine, University of Queensland, Brisbane, Australia
  1. Address correspondence and reprint requests to Prof. Thomas Marwick, MBBS, PhD, University of Queensland, Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Brisbane, Qld 4012, Australia. E-mail: tmarwick{at}soms.uq.edu.au
Diabetes Care 2005 Jul; 28(7): 1643-1648. https://doi.org/10.2337/diacare.28.7.1643
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE—Type 2 diabetes is associated with reduced exercise capacity, but the cause of this association is unclear. We sought the associations of impaired exercise capacity in type 2 diabetes.

RESEARCH DESIGN AND METHODS—Subclinical left ventricular (LV) dysfunction was sought from myocardial strain rate and the basal segmental diastolic velocity (Em) of each wall in 170 patients with type 2 diabetes (aged 56 ± 10 years, 91 men), good quality echocardiographic images, and negative exercise echocardiograms. The same measurements were made in 56 control subjects (aged 53 ± 10 years, 29 men). Exercise capacity was calculated in metabolic equivalents, and heart rate recovery (HRR) was measured as the heart rate difference between peak and 1 min after exercise. In subjects with type 2 diabetes, exercise capacity was correlated with clinical, therapeutic, biochemical, and echocardiographic variables, and significant independent associations were sought using a multiple linear regression model.

RESULTS—Exercise capacity, strain rate, Em, and HRR were significantly reduced in type 2 diabetes. Exercise capacity was associated with age (r = −0.37, P < 0.001), male sex (r = 0.26, P = 0.001), BMI (r = −0.19, P = 0.012), HbA1c (A1C; r = −0.22, P = 0.009), Em (r = 0.43, P < 0.001), HRR (r = 0.42, P < 0.001), diabetes duration (r = −0.18, P = 0.021), and hypertension history (r = −0.28, P < 0.001). Age (P < 0.001), male sex (P = 0.007), BMI (P = 0.001), Em (P = 0.032), HRR (P = 0.013), and A1C (P = 0.0007) were independent predictors of exercise capacity.

CONCLUSIONS—Reduced exercise capacity in patients with type 2 diabetes is associated with diabetes control, subclinical LV dysfunction, and impaired HRR.

  • HRR, heart rate recovery
  • LV, left ventricular

Clinical and observational studies have shown that exercise capacity is a strong predictor of cardiovascular and overall mortality (1). Patients with type 2 diabetes often complain of fatigue and reduced exercise capacity. Although these symptoms may be related to other disease conditions, such as hypertensive left ventricular (LV) hypertrophy or coronary artery disease, the presence of diabetes may independently contribute to the impaired exercise capacity (2).

The causes of reduced exercise capacity in type 2 diabetes are unknown. Overt LV diastolic dysfunction, evidenced by abnormal transmitral flow, has been associated with impaired functional capacity in uncomplicated well-controlled type 2 diabetes (2). However, primary myocardial disease may be present in many patients with type 2 diabetes, without overt systolic or diastolic dysfunction, independent of LV hypertrophy and coronary artery disease (3). Cardiac autonomic dysfunction may play an important role in the development of diabetic heart disease (3). Reduced heart rate recovery (HRR) immediately after exercise is an important indicator of cardiac autonomic dysfunction and contributes to cardiovascular morbidity and mortality in other diseases (4,5). In this study, we sought the extent to which diabetes control, impaired HRR, and subclinical LV dysfunction influence exercise capacity in patients with type 2 diabetes and without significant coronary artery disease.

RESEARCH DESIGN AND METHODS

In addition to the 195 patients with type 2 diabetes, we also studied 56 normal control subjects, who lacked cardiac symptoms, had an ejection fraction >50%, and had no history of coronary artery disease. Patients with moderate to severe valvular disease, atrial fibrillation or other severe arrhythmias, congenital heart disease, respiratory disease, and leg problems were excluded. Medications including β-blockers, calcium channel antagonists, ACE inhibitors, and nitrates were discontinued at least 12 h before the exercise test. The ethics committee of Princess Alexandra Hospital approved this project, and informed consent was obtained from each subject.

Clinical and biochemical variables

Fasting body weight was measured with the same scale, and height was measured at the same time. BMI was calculated as weight in kilograms divided by height in meters squared (2). Seated resting heart rate and blood pressure were measured in each patient after at least a 15-min rest but before the echocardiogram or stress test. Heart rate and blood pressure were also monitored during the exercise test.

Blood for glucose, HbA1c (A1C), insulin, urea, creatinine, and lipid profile was drawn from patients after fasting for at least 8 h and before oral antidiabetic drugs or insulin and treadmill exercise testing. Glucose was measured by the hexokinase method (Hitachi Modular Analyzer; Tokyo, Japan) and A1C by the high-performance liquid chromotography method (high-pressure liquid chromatography; Bio-Rad Variant). Insulin was assayed by two-site immunoenzymometric assay with fluorescence detection using a semiautomated immunoassay analyzer (Tosoh AIA-600; Edward Keller, Melbourne, Australia). Total cholesterol and triglycerides were determined enzymatically with the cholesterol oxidase-peroxidase amino phenazone phenol and the glycerol-3-phosphate oxidase-peroxidase amino phenazone phenol method (Hitachi Modular Analyzer). HDL cholesterol was measured using a homogeneous assay (Roche Diagnostics, Mannheim, Germany). Measurements were calibrated using secondary standards for automated analyzers (Roche Diagnostics). Low-density cholesterol was calculated using the Friedewald formula (6).

Conventional and tissue Doppler echocardiography

Subjects were examined in the left lateral decubitus position using a standard commercial ultrasound machine (Vivid 7; GE Vingmed, Horten, Norway) with a 3.5-MHz phased array probe. Both conventional echocardiographic data and color tissue Doppler data were acquired in the parasternal and three apical views (apical four-chamber, two-chamber, and long-axis views) using standard harmonic imaging and a high-frequency acquisition, respectively. The imaging angle was adjusted to ensure a parallel or perpendicular alignment of the beam with the myocardial segment of interest. Mitral inflow indexes were recorded. All images were saved digitally in raw-data format to a magneto optical disk for off-line analysis

LV diameters and wall thicknesses were measured from two-dimensional targeted M-mode echocardiography. LV mass was determined by Devereux’s formula (7). Resting LV end-diastolic and end-systolic volumes and ejection fraction were computed using a modified Simpson’s biplane method. Using standard commercial software (Echopac PC; GE-Vingmed, Horten, Norway), resting myocardial strain rate and basal segmental myocardial early diastolic velocity (Em) were measured in each of six walls (septal, lateral, anteroseptal, posterior, inferior, and anterior LV walls) in the three apical views using a 10 × 5–mm2 sample volume, as previously described (8,9). Variability in the measurement of myocardial strain rate and Em has been previously reported from our laboratory (8,9).

Stress testing

Exercise stress testing by treadmill was performed in all patients and control subjects, with the goal of excluding those with coronary artery disease. Subjects were encouraged to achieve their maximal exercise capacity. Blood pressure and cardiac status (using a 12-lead electrocardiogram) were monitored and recorded during the exercise test. Exercise capacity was calculated in metabolic equivalents, and HRR was measured as the difference between maximal heart rate and 1-min heart rate immediately after peak exercise. Abnormal exercise capacity was defined by the following formula: METs = 18.0–0.15 × age (10), and abnormal HRR was defined as HRR ≤18 beats per minute (5).

Regional wall motion was analyzed by two observers blinded to the patient’s clinical data; infarction was identified by resting wall motion abnormalities, and ischemia was identified by inducible wall motion abnormalities. Patients with LV ejection fraction <50% or infarction or ischemia were excluded.

Statistical analysis

Values were expressed as a means ± SD. Comparison between the groups was performed using Student’s independent-sample t test for continuous variables and the χ2 test for categorical variables. Univariate and multivariate analyses were used to examine correlations between exercise capacity and potential predictors. Data were analyzed using standard statistical software (SPSS, Chicago, IL). A P value <0.05 was considered statistically significant.

RESULTS

Clinical characteristics

Of 195 patients, 21 were excluded due to inducible wall motion abnormality and 4 due to poor images. Of the remaining 170 patients with type 2 diabetes (duration 10 ± 9 years), few had complications (30 had treated retinopathy, 27 had increased serum creatinine, and 9 had claudication or clinical signs of peripheral vascular disease). The treatment of diabetes included insulin (n = 61), metformin (n = 104), and sulfonylureas (n = 55). Insulin levels (mean value 17 ± 16 mU/l) were measured in 44 patients who were not taking exogenous insulin; in these patients, the homeostasis model assessment index was 5.9 ± 6.1, indicating significant insulin resistance.

Cardiovascular disturbances in type 2 diabetes

Table 1 summarizes the clinical, hemodynamic, and echocardiographic features of patients and control subjects. Abnormal HRR was present in 34 patients (20%) and 5 control subjects (9%). Exercise capacity, strain rate, Em, and HRR were significantly decreased in diabetic patients.

Predictors of maximal exercise capacity

Table 2 compares diabetic patients with normal and abnormal exercise capacity for age. Reduced exercise capacity was associated with increasing age (r = −0.37, P < 0.001), obesity (r = −0.19, P = 0.012), A1C (r = −0.22, P = 0.009), and longer duration of type 2 diabetes (r = −0.18, P = 0.021) and hypertension (r = −0.28, P < 0.001). Better exercise capacity was associated with male sex (r = 0.26, P = 0.001), preserved diastolic function (Em) (r = 0.43, P < 0.001), and preserved HRR (r = 0.42, P < 0.001). However, there was no correlation between exercise capacity and insulin levels or insulin resistance in the 44 patients who had no insulin treatment.

The independent predictors of exercise capacity (model R2 = 0.38) were age (β = −0.33, P < 0.001), male sex (β = 0.18, P = 0.007), BMI (β = −0.24, P = 0.001), Em (β = 0.16, P = 0.032), HRR (β = 0.18, P = 0.013), and A1C (β = −0.18, P = 0.0007). Significant correlations were not found between exercise capacity and LV systolic function, although strain rate (r = 0.142, P = 0.065) had a trend to correlate with exercise capacity. Although Em was a correlate of exercise capacity in both women (β = 0.16, P = 0.013) and men (β = 0.29, P = 0.004), the other independent predictors of exercise capacity in women (age [β = 0.32, P = 0.004] and BMI [β = −0.35], P = 0.013) were different from men (HRR [β = 0.31, P = 0.002] and type 2 diabetes duration [β = −0.28, P = 0.009]).

Correlates of abnormal HRR in type 2 diabetes

Table 3 shows comparison of clinical and echocardiographic characteristics of diabetic patients with and without abnormal HRR. Reduced HRR is negatively associated with increasing age (r = −0.30, P < 0.001), higher resting heart rate (r = −0.21, P = 0.007) and systolic blood pressure (r = −0.19, P = 0.016), longer duration of diabetes (r = −0.15, P = 0.048) or hypertension history (r = −0.24, P = 0.002), and A1C (r = −0.22, P = 0.005). Preserved HRR is associated with preserved diastolic function (Em) (r = 0.37, P < 0.001), systolic function (strain rate) (r = 0.30, P < 0.001), and exercise capacity (r = 0.42, P < 0.001). However, there was no correlation between HRR and insulin levels or insulin resistance in the 44 patients who had no insulin treatment.

All factors associated with HRR were entered into a forward stepwise multiple linear regression model (R2 = 0.30). The independent predictors of HRR were age (β = −0.21, P = 0.009), resting heart rate (β = −0.20, P = 0.005), strain rate (β = 0.22, P = 0.002), exercise capacity (β = 0.25, P = 0.002), and A1C (β = −0.15, P = 0.042).

CONCLUSIONS

Exercise capacity is a powerful predictor of all-cause and cardiovascular mortality (1). The current study demonstrates that in addition to the expected associations with aging, female sex, and obesity, impaired exercise capacity in type 2 diabetes is associated with poor diabetes control, LV diastolic dysfunction, and reduced HRR.

Exercise capacity and diabetes control

Previous studies have shown that type 2 diabetes is associated with significant cardiopulmonary dysfunction. The association of poor glycemic control with worse exercise capacity in this study is consistent with a previous large study in asymptomatic type 2 diabetes (11). Other studies have shown that A1C has an inverse correlation with maximum oxygen uptake (12), work capacity (13), or exercise duration (14). Importantly, chronic maintenance of near normoglycemia is associated with improved cardiopulmonary function (15), and exercise capacity increased 24% after improved glycemic control was attained after initiating continuous subcutaneous insulin infusion (16).

The mechanism of the association between type 2 diabetes control and exercise capacity is unclear. Poor glycemic control has been associated with increased stiffness of large conduit vessels. The compliance of the aorta is believed to be of prime importance for modulating coronary artery blood flow, which has important consequences for myocardial work capacity and, therefore, exercise capacity (17). Poor diabetes control has been shown to be associated with subclinical LV dysfunction (18,19). Insulin resistance is associated with poor diabetes control, and previous studies demonstrated a negative correlation between insulin resistance and peak exercise capacity in diabetic patients (20). Unfortunately, insulin resistance did not correlate with exercise capacity in this study, perhaps due to the limited number of patients included in the subgroup. However, impaired exercise capacity may be observed in mild and even pre-diabetic states, where insulin resistance may be an important contributor. Glycosylation may impair the function of a number of proteins, and vascular or endothelial dysfunction may be a plausible connection between reduced exercise capacity and the metabolic disturbances associated with poor diabetes control, including abnormalities in glucose transport and usage, increased free fatty acids, carnitine deficiency, and changes in calcium homeostasis.

Exercise capacity and LV function

In this study, the correlation between LV function and diabetes control in diabetic patients (3) may also suggest that lower exercise capacity is due to myocardial dysfunction. The association in this study between LV diastolic dysfunction and exercise performance in type 2 diabetes is consistent with results from previous studies in patients without (21) and with (2) type 2 diabetes. The lack of correlation between exercise capacity and LV systolic function in this study also confirms previous studies showing a poor correlation of exercise capacity with indexes of LV systolic function in patients with dilated cardiomyopathy (22) and hypertensive heart disease (23).

Patients with type 2 diabetes have an impaired cardiac output response to increasing workload, and this is further impaired by hypertension (24). LV diastolic dysfunction caused by diabetes is associated with decreased LV compliance, which results in an upward left shift of the LV end-diastolic pressure-volume relation, leading to the limited ability to increase cardiac output by means of the Frank-Starling mechanism during exercise (25). The relatively fixed stroke volume associated with type 2 diabetes may restrain cardiac output during maximal performance and limit exercise capacity (25).

Exercise capacity and autonomic cardiac function

Exercise results in prompt withdrawal of vagal tone and subsequent sympathetic activation, while recovery is associated with parasympathetic activation followed by sympathetic withdrawal. HRR correlates with vagal activity. Previous studies have shown that reduced HRR is associated with type 2 diabetes (26).

The development of reduced HRR is associated with type 2 diabetes only among subjects with both poor physical fitness and autonomic dysfunction (26). Exercise training improves both autonomic function and exercise capacity in type 2 diabetes (27). The results of the current study are consistent with previous studies (13) and suggest that abnormalities in HRR correlate with exercise performance in diabetes. The mechanism of this may reflect a role for autonomic dysfunction, although this requires further study.

Persistent hyperglycemia in diabetes may weaken parasympathetic control and enhance sympathetic activity (28), consistent with independent prediction of HRR by A1C levels in the current study. Indeed, increased resting heart rate itself may reflect autonomic dysfunction. Patients with high parasympathetic activation usually have low resting heart rate and baseline oxygen consumption and may achieve high workload for a certain level of oxygen consumption. Abnormal cardiac autonomic function has been associated with poor cardiac output responses to exercise in diabetes (29), probably due to abnormal hemodynamic regulation during exercise. In addition, an indirect link between cardiac autonomic dysfunction and impaired exercise capacity is demonstrated by associations of cardiac autonomic dysfunction with insulin resistance (30) or poor glycemic control (as in the current study) and impaired resting left ventricular diastolic filling (31).

Limitations

Although this study documents an association between exercise capacity and poor diabetes control, evidence of diabetic myocardial disease and probable autonomic dysfunction (reduced HRR), such a cross-sectional study cannot define a causal relationship. Identifying the causal relationships will require a number of intervention studies, and we have initiated this process with interventions to improve insulin resistance and glycemic control.

While tissue Doppler parameters appear to be less load dependent than conventional blood flow Doppler, they are certainly not load independent. Consequently, higher levels of blood pressure in the group with reduced exercise capacity may be a contributor to reduced myocardial function. Nonetheless, our data do show that the association of tissue velocity with exercise capacity is independent of blood pressure. Finally, the type and duration of comorbidity and medications may affect exercise capacity, even though we failed to show a correlation of therapy with exercise capacity in this study.

This study demonstrates that impaired exercise capacity in type 2 diabetes is not only associated with physical characteristics such as age, sex, and BMI but also with subclinical LV dysfunction and cardiac autonomic dysfunction. The mechanisms of this association will be clarified by subsequent intervention trials, but it seems likely that these effects are linked by diabetes control.

View this table:
  • View inline
  • View popup
Table 1—

Comparison of clinical and echocardiographic characteristics in patients with diabetes and control subjects

View this table:
  • View inline
  • View popup
Table 2—

Significant differences in clinical and echocardiographic characteristics between patients with and without abnormal exercise capacity

View this table:
  • View inline
  • View popup
Table 3—

Comparison of clinical and echocardiographic characteristics of diabetic patients with and without abnormal HRR

Acknowledgments

This study was supported in part by a Centres of Clinical Research Excellence Award from the National Health and Medical Research Council of Australia.

We gratefully acknowledge the contributions of Rodel Leano, BSc; Chiew Wong, MBBS, FRACP; and Brian A. Haluska, MSc, RDCS, AMS, FASE.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted April 18, 2005.
    • Received January 4, 2005.
  • DIABETES CARE

References

  1. ↵
    Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD, Lauer MS: Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 30: 641–648, 1997
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Poirier P, Garneau C, Bogaty P, Nadeau A, Marois L, Brochu C, Gingras C, Fortin C, Jobin J, Dumesnil JG: Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 85: 473–477, 2000
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25: 543–567, 2004
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS: Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 290: 1600–1607, 2003
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer MS: Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation 104: 1911–1916, 2001
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499–502, 1972
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55: 613–618, 1977
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH: Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 41: 611–617, 2003
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Fang ZY, Najos-Valencia O, Leano R, Marwick TH: Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol 42: 446–453, 2003
  10. ↵
    Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A: Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol 22: 175–182, 1993
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Demir I, Ermis C, Altunbas H, Balci MK: Serum A1C levels and exercise capacity in diabetic patients. Jpn Heart J 42: 607–616, 2001
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Vanninen E, Uusitupa M, Siitonen O, Laitinen J, Lansimies E: Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention. Diabetologia 35: 340–346, 1992
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Barkai L, Peja M, Vamosi I: Physical work capacity in diabetic children and adolescents with and without cardiovascular autonomic dysfunction. Diabet Med 13: 254–258, 1996
    OpenUrlCrossRefPubMed
  14. ↵
    Baum VC, Levitsky LL, Englander RM: Abnormal cardiac function after exercise in insulin-dependent diabetic children and adolescents. Diabetes Care 10: 319–323, 1987
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Niranjan V, McBrayer DG, Ramirez LC, Raskin P, Hsia CC: Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med 103: 504–513, 1997
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Thuesen L, Christiansen JS, Sorensen KE, Falstie-Jensen N, Christensen CK, Hermansen K, Mogensen CE, Henningsen P: Exercise capacity and cardiac function in type 1 diabetic patients treated with continuous subcutaneous insulin infusion: a controlled study. Scand J Clin Lab Invest 46: 779–784, 1986
    OpenUrlPubMedWeb of Science
  17. ↵
    Kingwell BA: Large artery stiffness: implications for exercise capacity and cardiovascular risk (Review). Clin Exp Pharmacol Physiol 29: 214–217, 2002
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Vinereanu D, Nicolaides E, Tweddel AC, Madler CF, Holst B, Boden LE, Cinteza M, Rees AE, Fraser AG: Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond ) 105: 591–599, 2003
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Holzmann M, Olsson A, Johansson J, Jensen-Urstad M: Left ventricular diastolic function is related to glucose in a middle-aged population. J Intern Med 251: 415–420, 2002
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Ugur-Altun B, Altun A, Tatli E, Arikan E, Tugrul A: Relationship between insulin resistance assessed by HOMA-IR and exercise test variables in asymptomatic middle-aged patients with type 2 diabetes. J Endocrinol Invest 27: 455–461, 2004
    OpenUrlPubMed
  21. ↵
    Genovesi-Ebert A, Marabotti C, Palombo C, Giaconi S, Rossi G, Ghione S: Echo Doppler diastolic function and exercise tolerance. Int J Cardiol 43: 67–73, 1994
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Lapu-Bula R, Robert A, De Kock M, D’Hondt AM, Detry JM, Melin JA, Vanoverschelde JL: Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 83: 728–734, 1999
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    Guazzi M, Brenner DA, Apstein CS, Saupe KW: Exercise intolerance in rats with hypertensive heart disease is associated with impaired diastolic relaxation. Hypertension 37: 204–208, 2001
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Babalola RO, Ajayi AA: A cross-sectional study of echocardiographic indices, treadmill exercise capacity and microvascular complications in Nigerian patients with hypertension associated with diabetes mellitus. Diabet Med 9: 899–903, 1992
    OpenUrlPubMedWeb of Science
  25. ↵
    Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 17: 1065–1072, 1991
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    Carnethon MR, Jacobs DR Jr, Sidney S, Liu K: Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care 26: 3035–3041, 2003
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Loimaala A, Huikuri HV, Koobi T, Rinne M, Nenonen A, Vuori I: Exercise training improves baroreflex sensitivity in type 2 diabetes. Diabetes 52: 1837–1842, 2003
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Vanninen E, Uusitupa M, Lansimies E, Siitonen O, Laitinen J: Effect of metabolic control on autonomic function in obese patients with newly diagnosed type 2 diabetes. Diabet Med 10: 66–73, 1993
    OpenUrlPubMedWeb of Science
  29. ↵
    Roy TM, Peterson HR, Snider HL, Cyrus J, Broadstone VL, Fell RD, Rothchild AH, Samols E, Pfeifer MA: Autonomic influence on cardiovascular performance in diabetic subjects. Am J Med 87: 382–388, 1989
    OpenUrlPubMedWeb of Science
  30. ↵
    Lind L, Andren B: Heart rate recovery after exercise is related to the insulin resistance syndrome and heart rate variability in elderly men. Am Heart J 144: 666–672, 2002
    OpenUrlPubMedWeb of Science
  31. ↵
    Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG: Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism 52: 1056–1061, 2003
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 28 (7)

In this Issue

July 2005, 28(7)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Determinants of Exercise Capacity in Patients With Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Determinants of Exercise Capacity in Patients With Type 2 Diabetes
Zhi You Fang, James Sharman, Johannes B. Prins, Thomas H. Marwick
Diabetes Care Jul 2005, 28 (7) 1643-1648; DOI: 10.2337/diacare.28.7.1643

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Determinants of Exercise Capacity in Patients With Type 2 Diabetes
Zhi You Fang, James Sharman, Johannes B. Prins, Thomas H. Marwick
Diabetes Care Jul 2005, 28 (7) 1643-1648; DOI: 10.2337/diacare.28.7.1643
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort
  • Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes
  • High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.